Invcity Editorial Desk
AIIMS Nagpur added a corneal treatment central India didn't have
A single Corneal Collagen Cross-Linking system, installed in one operation theatre in July 2026, means a specific eye condition no longer requires a trip to a coastal metro to treat.
On 16 July 2026, AIIMS Nagpur's Department of Ophthalmology installed a Corneal Collagen Cross-Linking (CXL) system in Operation Theatre No. 7 — a small, specific piece of equipment news that's worth reading as evidence of something larger than one hospital's procurement list.
What the equipment actually does
The CXL system treats progressive corneal ectatic disorders — keratoconus, pellucid marginal degeneration, and iatrogenic corneal ectasia — conditions where the cornea thins and bulges in ways that standard glasses or contact lenses can't correct, and which historically required patients to travel to a handful of specialised centres for treatment. Department head Dr. Puja Hingorani-Bang, along with cornea specialists Dr. Purvasha Narang and Dr. Shital Nannaware, will run the service; AIIMS Nagpur's Executive Director and CEO, Dr. Prashant P. Joshi, framed the installation as giving "patients from Nagpur and the surrounding regions... access to world-class treatment for corneal diseases within AIIMS Nagpur."
A single machine in one operation theatre doesn't sound like regional infrastructure. But a treatment that used to require a trip to Mumbai or Delhi and now requires a trip across Nagpur is exactly that.
Why the location, not just the equipment, is the story
Nagpur's whole regional identity runs on being the place equidistant from everywhere else in India — a rail and air-cargo hub built on central geography rather than local demand. A specialised medical service arriving at a central-India institution carries the same logic: patients who would otherwise travel to a coastal metro for corneal treatment now have a nearer option, and "nearer" is doing real work in a country where corneal ectatic disorders often go undertreated outside major cities specifically because the equipment and the specialists cluster in a handful of places.
What this doesn't claim
This is one installation at one hospital, not a transformation of eye care access across central India — AIIMS Nagpur's own announcement frames it as expanding what the institution itself can now offer, not as solving a regional shortage single-handedly. The honest scope of the story is a public medical institution adding a specific, previously-unavailable capability, in a city whose institutions have a track record of building around gaps other places haven't filled yet.
Sources